SANTEN
LIVE

Serial Number

79228774

Owner

SANTEN PHARMACEUTICAL CO., LTD.

Attorney

John Lyhus

Filing Date

Feb 16, 2018

Add to watchlist:

No watchlists yet
View on USPTO

SANTEN Trademark

Serial Number: 79228774 • Registration: 5730380

SANTEN is a trademark filed by SANTEN PHARMACEUTICAL CO., LTD. on February 16, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

SANTEN PHARMACEUTICAL CO., LTD. (50 trademarks)

9-19, SHIMOSHINJO 3-CHOME
OSAKA 533-8681 , JP

Entity Type: 01

Trademark Details

Filing Date

February 16, 2018

Registration Date

April 23, 2019

Published for Opposition

February 5, 2019

Goods & Services

Collyrium; eye drops; ophthalmological preparations; pharmaceutical preparations for treatment of cataracts; pharmaceutical preparations for treatment of glaucoma; pharmaceutical preparations for treatment of ocular hypertension; ophthalmic ointments for treatment of eye disease; pharmaceutical preparations for use in eye injections; pharmaceutical preparations for treatment of pinguecula; pharmaceurical preparations for treatment of chalazion; pharmaceutical preparations for treatment of uveitis; eye drops for treatment of keratoconjunctival epithelial disorder; antibacterial eye drops; antiallergic eye drops; oiled paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for medical use; capsules sold empty for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive medical plasters; bandages for dressings; antiseptic liquid bandages; breast- nursing pads; dietary supplements for humans; nutritional supplements; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; food for babies; dietary supplements for animals; dental cements; materials for dental fillings and dental prostheses; dental waxes; disposable diapers for incontinence; mothproofing paper; lactose for pharmaceutical purposes

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Dec 13, 2024 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Dec 13, 2024 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 2, 2024 APRE
TEAS SECTION 71 & 15 RECEIVED
Apr 25, 2024 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 23, 2024 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 1, 2020 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 30, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 14, 2019 FICS
FINAL DISPOSITION PROCESSED
Aug 14, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 23, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 23, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 5, 2019 NPUB
PUBLISHED FOR OPPOSITION
Feb 5, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Feb 1, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 16, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 16, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 16, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 29, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 13, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 13, 2018 CRFA
ASSIGNED TO LIE
Dec 7, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 4, 2018 TROA
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Aug 7, 2018 CORN
REFUSAL PROCESSED BY IB
Jul 13, 2018 RFNT
CORRECTION TRANSACTION RECEIVED FROM IB
Jul 13, 2018 CRCV
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 18, 2018 RFCS
REFUSAL PROCESSED BY MPU
Jun 18, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 9, 2018 RFCR
NON-FINAL ACTION WRITTEN
Jun 8, 2018 CNRT
ASSIGNED TO EXAMINER
Jun 1, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 23, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 19, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 16, 2018 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Mar 15, 2018 SDRC